Does SECUKINUMAB Cause Injection site hypoaesthesia? 20 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Injection site hypoaesthesia have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
20
Reports of Injection site hypoaesthesia with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site hypoaesthesia From SECUKINUMAB?
Of the 20 reports, 1 (5.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Injection site hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Injection site hypoaesthesia?
DUPILUMAB (94)
ADALIMUMAB (84)
ETANERCEPT (73)
EPINEPHRINE (62)
HYDROXYPROGESTERONE CAPROATE (60)
TIRZEPATIDE (58)
EVOLOCUMAB (56)
DEOXYCHOLIC ACID (52)
ONABOTULINUMTOXINA (47)
GLATIRAMER (39)
Which SECUKINUMAB Alternatives Have Lower Injection site hypoaesthesia Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG